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External biliary fistula (BF) or ileal bypass (IB) was performed in dogs at the time of or 2 weeks 
after portacaval shunt (PCS). The pathologic changes in the dog livers 2 to 4 weeks later were 
compared to those caused by PCS alone. Histopathologic differences between PCS alone vs. PCS 
plus BF or IB could not be found. Thus, the experiments did not confirm recent observations by 
others in rats that BF prevents or reverses the hepatic injury of PCS. As estimated by plasma 
mevalonic acid determinations, the increase in hepatic cholesterol synthesis that is characteristic 
after BF or IB was suppressed in animals with PCS. BF and m reduced but did not eliminate the 
postprandial elevation in serum bile acid that occurs after PCS. The findings have possible 
relevance in planning the treatment of patients with familial hypercholesterolemia with the 
combined use of PCS and lB. 
Completely diverting portacaval shunt (PCS), also 
called Eck's fistula, has been used for its effect upon the 
metabolism of patients with glycogen storage disease (1), 
familial hypercholesterolemia (2, 3), and aI-antitrypsin 
deficiency (4). The metabolic palliation in these diseases 
has been ascribed in part to the hepatocyte alterations 
caused by portal diversion including atrophy, deglycogen-
tation, fat accumulation, increased mitosis, and major 
ultrastructural disruptions (2, 4-9). These changes are 
identical in rats, dogs, and humans (5). Thus, research 
with any of these species should be applicable to all in 
spite of the fact that humans are unusually resistant to 
the hepatic encephalopathy that may complicate PCS. 
Balabaud et a1. (10) and Bioulac et a1. (11) have 
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reported that the hepatocyte abnormalities caused by 
PCS in rats could be prevented or reversed by simulta-
neous or delayed external bile fistula (BF). They specu-
lated that the liver injury of Eck fistula had been avoided 
in their animals by preventing the elevation in serum 
bile acids that is a characteristic finding after PCS (12, 
13). 
We report here an unsuccessful attempt in dogs to 
confirm this protective effect of BF. In addition, the bile 
salt and bile acid depleting procedure of ileal bypass (IB) 
also failed to prevent the hepatic changes after PCS. The 
findings of this study have potential significance in plan-
ning how to manage patients treated for familial hyper-
cholesterolemia with portal diversion. 
MATERIALS AND METHODS 
OPERATIVE PROCEDURES 
After endotracheal intubation, the operations and sac-
rifice procedures were performed under anesthesia with 
pentobarbital sodium supplemented with xylazine (Rom-
pun®) and succinylcholine chloride (Anectine(!J). The 
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technique for PCS consisted of side-to-side anastomosis 
of the portal or superior mesenteric vein to the inferior 
vena cava after excision of an ellipse from both vessels. 
After completion of the anastomosis, the portal vein was 
ligated at its bifurcation in the liver hilum,· taking pains 
to eliminate any incoming venous tributaries to the por-
tal branches above the site of ligation. 
IB was performed as described by Buchwald et a1. (14). 
The small intestine from the ligament of Treitz to the 
ileocecal junction was measured in the units of wound 
length, and it was divided at the junction of the proximal 
two-thirds and distal one-third. The end of the proximal 
segment was anastomosed in two layers to the side of the 
cecum 6 cm distal to the ileocecal junction. The distal 
segment of bypassed bowel was closed in two layers and 
sutured to the cecum proximal to the ileocolostomy to 
prevent intussusception. 
For complete external biliary diversion, a silastic cath-
eter was inserted 1 to 2 cm into the transected common 
duct and tied in place. The catheter was brought through 
a right flank stab wound and led subcutaneously to the 
back of the neck where it was allowed to drain freely. 
The gallbladder was removed. 
ANIMAL GROUPS 
Fifty-five adult mongrel dogs, with a starting weight 
of 10 to 34 kg, contributed to the final data. The dogs 
were preconditioned in the laboratory facility for several 
weeks and received standard dog chow containing ap-
proximately 25% protein and 8% fat. The same diet was 
continued postoperatively. An additional 100 experi-
ments could not be completed because of a variety of 
complications including intussusception, infection, and 
lethal encephalopathy. 
The design of the completed experiments is shown in 
Table 1. The duration of most studies (Groups 4 to 7) 
was 4 weeks; controls were the animals with PCS alone 
(Group 3). However, the animals tolerated the simulta-
neous combination of BF and PCS so poorly that an 
endpoint of 3 weeks was accepted (Group 2), necessitat-
ing a separate control series of dogs studied for 3 weeks 
after PCS alone (Group 1). 
PATHOLOGIC STUDIES 
Biopsy of one of the left lobes of the liver was per-
formed at each surgical procedure and at sacrifice. The 
hepatic tissues were fixed in 10% normal buffered For-
malin (aqueous solution offormaldehyde), and additional 
smaller samples were initially fixed in gluteraldehyde 
solution and postfixed in osmic acid and embedded in 
Epon (synthetic embedding medium). Two hours prior 
to sacrifice, 2 mCi per kg body weight tritiated thymidine 
(specific activity 47 mCi) were injected intravenously. In 
addition to the final liver biopsy, biopsy of the right 
kidney was performed. The patency of the vascular an-
astomosis and the absence of venous tributaries superior 
to the portal vein ligation were verified. The length of 
the intestinal bypass, position of the common duct cath-
eter, and the presence of any intraabdominal abnormal-
ities were also determined. 
Before weighings, the autopsy livers were cleaned of 
extraneous tissue, the extrahepatic biliary tract, and 
other hilar structures. The liver weight (including the 
final biopsy) was converted to the percentage of both the 
preoperative and final body weights. Only the latter 
values will be reported. 
For histopathologic studies, frozen sections of the liver 
were cut and stained with Sudan IV for fat. Paraffin 
sections were stained with hematoxylin and eosin, Gor-
don and Sweet's silver impregnation method for reticulin 
fibers, Pearl's Prussian blue method for iron, trichrome 
for collagen and fibrin, periodic acid-Schiff reaction for 
glycogen, and Pearce's method for ceroid and lipofuscin. 
Half-micron and ultrathin sections were cut from the 
Epon-embedded material. The former were stained with 
Azur II for examination by light microscopy, while the 
latter were stained with lead citrate and examined under 
a Phillips 300 electron microscope. The size of the mid-
zonal hepatocytes before and after PCS were determined 
by tracing large numbers of liver cells on standard thick-
ness paper, cutting out the silhouettes, and weighing 
them (9). Midzonal hepatocytes identified in half-micron 
Epon sections were also used for measuring on electron 
micrographs the area of rough and smooth endoplasmic 
reticulum within these cells and the dimensions of mi-
TABLE 1. DESIGN OF COMPLETED EXPERIMENTS, WEIGHT CHANGES, AND LIVER!BODY WEIGHTS (MEAN ± S.D.) 
No. of Duration of Dog weight 1088 Liver/body Group 
nperiments Description esperiment (% of original) p. weight (%) p. (weeks) 
1 6 PCS (control) 3 18.5 ± 4.8 1.8 ± 0.2 
2 10 PCS+BF 3 14.4 ± 8.8 NSb 2.5 ± 0.3 <0.01 
3 10 PCS (control) 4 14.4 ± 6.5 1.7 ± 0.4 
4 5 PCS + BF (staged) 4 21.4 ± 6.9 NS 2.4 ± 0.3 <0.05 
(2 + 2) 
5 5 IB 4 14.4 ± 6.5 NS 2.5 ± 0.3 <0.05 
6 10 PCS + IB 4 17.9 ± 10.1 NS 1.7 ± 0.2 NS 
7 10 PCS + IB (staged) 4 25.2 ± 8.3 <0.05 2.52 ± 0.3 <0.01 
(2 + 2) 
• Statistical evaluations (Student's t test) of the percentage changes were Group 2 vs. Group 1 (control) and Groups 4 to 7 vs. Group 3 
(control). 
b NS, not significant. 
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tochondria, lysosomes, lipid inclusions, and clumps of 
glycogen by the morphometric methods of Loud (15). 
Autoradiography was performed on dewaxed paraffin 
sections of liver using Ilford K2 nuclear emulsion. Ex-
posure was for 3 to 12 weeks until counts of the labeled 
nuclei stopped increasing. All histopathologic observa-
tions were recorded without knowledge of the experimen-
tal groups from which the specimens came and subse-
quently decoded. 
BIOCHEMICAL STUDIES 
After an overnight fast, serum samples were obtained 
for determination of bilirubin and SGOT. Total serum 
cholesterol (16) and triglyceride (17) concentrations were 
determined by enzymatic analysis. In addition, 2-hr post-
prandial serum samples were obtained for analysis of 
total serum bile acids by the enzymatic-fluorometric 
analysis of Brunsgaard et a1. (18). Total 3 a-hydroxy bile 
acids were measured. 
Fasting blood samples collected in heparin tubes were 
separated and the plasma frozen for eventual measure-
ment of plasma mevalonic acid concentrations by the 
method of Popjak et a1. (19), as modified by Parker et a1. 
(20). Attempts to analyse postprandial samples for mev-
alonic acid proved to be impractical because of the pres-
ence in the plasma of substances that interfered with the 
measurement. 
Usually, blood samples for the various analyses were 
obtained preoperatively about 2 weeks after surgery and 
at the time of sacrifice. 
RESULTS 
POSTOPERATIVE BEHAVIOR 
Weight loss occurred in all of the animal groups (Table 
1), to the most extreme degree in the animals of Group 
7 which had pes and IB in two stages. Hair loss was 
severe in all of the dogs subjected to pes, with or without 
the additional procedures of BF or IB. 
Several animals in Groups 1 to 4, 6, and 7 had findings 
of hepatic encephalopathy including ataxia and convul-
sions. The only experimental group which was spared 
these classical complications of Eck fistula was that with 
IB alone (Group 5). 
PATHOLOGIC STUDIES 
Gross Liver Weight. In normal unoperated dogs, the 
liver weight per body weight percent is 2.43 ± 0.66 (S.D.) 
per cent (21). Using the reduced final body weight as 
reference (Table 1), the control animals with pes alone 
(Groups 1 and 3) had a diminished liver weight per body 
weight. The liver weight per body weight per cent was 
less severely reduced in animals given BF plus pes 
(Groups 2 and 4), in animals with IB alone (Group 5), 
and after pes plus delayed IB (Group 7). 
Histopathologic Observations. The biopsy specimens 
obtained before the initial operation were normal by light 
and electron microscopy. Few hepatocytes were seen In 
mitosis. 
After pes (Groups 1 and 3), the hepatocytes shrank 
to roughly half their original size (Table 2). They became 
irregular in shape and lacked glycogen. A small excess of 
fat accumulated in their cytoplasm. Measured on elec-
tron micrographs, the rough endoplasmic reticulum was 
found to be reduced in amount to less than one-third the 
quantity found preoperatively, and there were fewer ri-
bosomes on the membranes. What remained of the rough 
endoplasmic reticulum was dilated and fragmented. The 
amount of smooth endoplasmic reticulum and the num-
ber of free ribosomes were increased. The Golgi appara-
tus was poorly developed and some of the mitochondria 
and their cristae disrupted. Lipid droplets were common 
in the cytoplasm of the hepatocytes. Glycogen granules 
were greatly reduced in number. The Kupffer cells were 
increased in number and size, and their cytoplasm con-
tained abundant ceroid, lipfuscin, and lipid. Take up of 
thymidine by the hepatocyte nuclei increased roughly 9-
fold over normal values by 3 and 4 weeks after pes 
(Table 2). There was a corresponding rise in the mitotic 
count. In Groups 4 and 7, all of these changes were 
established by 2 weeks, at which time BF or IB was 
performed at a second stage (Table 2). 
The addition of IB (Group 7) or BF (Group 4) 2 weeks 
TABLE 2. HISTOPATHOLOGIC STUDIES 
Group Description n 
Before 
1 PCS 6 0.365 ± 0.048 
2 PCS+ BF 10 0.358 ± 0.070 
3 PCS 10 0.354 ± 0.031 
4 PCS + BF (staged) 5 0.356 ± 0.063 
5 IB 5 0.351 ± 0.034 
6 PCS + IB 10 0.354 ± 0.048 
7 PCS + IB (staged) 10 0.358 + 0.054 
Hepatocyte size units 
(mean ± S.D.) 
2 weeks 
0.15got ± 0.025 
0.173d ± 0.036 
Sacrifice 
0.141 ± 0.020 
0.158 ± 0.020 
0.154 ± 0.036 
0.158 ± 0.009 
0.328 ± 0.035 
0.138 ± 0.011 
0.162 ± 0.030 
p. 
NS' 
NS 
<0.01 
NS 
NS 
No. of labeled 
hepatocytes 
per 100 
hepatocytes' 
(mean ± S.D.) 
Sacrifice 
13.8 ± 1.6 
13.9 ± 1.2 
14.3 ± 1.8 
15.1 ± 2.9 
1.64 ± 0.3 
13.8 ± 2 
16.1 ± 1.6 
G Statistical comparisons were between Group 2 vs. Group 1 (control) and Groups 4 to 7 at sacrifice vs. Group 3 (control). 
b In normal unoperated dogs, the labeling is 1.6 ± 0.4 (7) . 
• NS, not significant. 
d The atrophy at 2 weeks was explained by the pes which was the first stage operation. 
p. 
NS 
NS 
<0.001 
NS 
NS 
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after PCS increased the amount of iron pigment in the 
Kupffer cells. Dogs with BF, whether this was performed 
at the time of PCS (Group 2) or later (Group 4), also 
developed cholestasis with bile "thrombi" in the centri-
lobular canaliculi. The severity of the abnormalities 
caused by PCS was neither increased nor alleviated by 
any of the additional procedures. IB by itself caused no 
structural alterations of the liver and the uptake 
of thymidine by the hepatocytes remained normal 
(Table 2). 
BIOCHEMICAL STUDIES 
Bilirubin and Transaminases. Elevations in serum bil-
irubin were common only in the animals of Groups 2 
which were submitted to simultaneous PCS and BF 3 
weeks before sacrifice (Table 3). Five of the dogs in this 
group had serum bilirubin concentrations > 1.2 mgm % 
at some time postoperatively, whereas only 1 dog of the 
46 in the other six groups had this finding. Minor serum 
transaminase elevations occurred postoperatively in all 
of the experimental groups (Table 3). 
Serum Lipids. Serum cholesterol was lowered in all of 
the experimental groups, to the least degree in animals 
with IB alone (Table 4). The decreases seen after PCS 
alone were not augmented with the addition of BF or IB 
(Table 4). Significant changes in serum triglycerides were 
not caused by any of the experimental procedures. 
Mevalonic Acid. Plasma mevalonic acid was unchanged 
(Group 3 and following Stage 1 of Group 7) or depressed 
(Group 1) after PCS (Table 4), but was tripled after IB 
alone (Group 5). Small or no increases in mevalonic acid 
occurred in the animals of Groups 6 and 7 in which PCS 
wad combined with IB (Table 4). A small increase was 
seen in the dogs of Group 2 which was submitted to 
simultaneous PCS and BF (Table 4). 
Postprandial Serum Bile Acids. Major increases were 
caused by pes alone (Table 5). After IB alone, there was 
no change from baseline. When either BF or IB was 
combined with PCS, serum bile acids increased at 1 to 2 
weeks and/or before sacrifice, but to significantly lower 
levels at 2 weeks or at sacrifice than after PCS alone. 
The clearest results were in the staged procedures of 
Groups 4 and 7 in which the major increases after 2 
weeks reflected pes alone. BF (Group 4) and IB (Group 
7) then caused significant subsequent falls in serum bile 
acids. 
Special Assessment of Group 2. The results of the 
histopathologic and biochemical studies were separated 
into those obtained from dogs which did or did not 
develop jaundice (Table 6). Except for the bilirubin, there 
were no obvious differences between the two subgroups. 
DISCUSSION 
PCS deprives the liver of first-pass exposure to hor-
mones (especially insulin) and other putative hepato-
trophic factors from the splanchnic viscera with conse-
quent morphologic changes in the rough endoplasmic 
reticulum that explain reductions in many biosynthetic 
TABLE 3. EFFECT OF EXPERIMENTS ON SERUM BILIRUBIN AND SGOT AT SACRIFICE 
No. of dogs 
Group Deaeription Bilirubin p" with SGOT (mg% sacrifice) bilirubin (mU/ml sacrifice) 
;01.2 mg/dl 
1 PCS 1.1 ± 0.2 0/6 30±6 
2 pes + BF 2.8 ± 1.8 NSb 5/10 45 ± 31 NS 
3 PCS 1.2 ± 0.7 NS 1/10 36 ± 30.6 
4 pes + BF (staged) <1 NS 0/5 49.2 ± 24 NS 
5 IB 1.1 ± 0.2 NS 0/5 19.4 ± 17.4 NS 
6 PCS + IB <1 NS 0/10 11.9 ± 8 <0.05 
7 PCS + IB (staged) 1.08 ± 0.2 NS 0/10 27.6 ± 14.5 NS 
• Statistical evaluations were: Group 2 vs. Group 1 (control) and Groups 4 to 7 VS. 3 (control). Bilirubin normal, <1.2 mg/dl; SGOT normal, 
.;;50rnU/ml. 
b NS, not significant. 
TABLE 4. EFFECT OF EXPERIMENTS ON SERUM CHOLESTEROL AND PLASMA MEVALONIC ACID 
Cholesterol (mg%) % Decrease p. Mevalonic acid (nm/liter) 
Group Description 
±% p' 
Before 2 weeks Saeri- 2 weeks Sacri- 2 weeks Sacri- Before 2 weeks Varia-fice fiee fice Hon 
1 PCS 157 ± 38 99±33 92± 14 41 42 59±26 26±4 -56 
2 PCS+ BF 196 ± 100 120± 30 126 ± 22 38 36 NS' NS 79 ± 56 116 ± 65 +46 <0.01 
3 PCS 168± 36 127 ± 29 126± 40 24 25 58± 21 57 ± 11 -1.8 
4 PCS + BF 139 ± 37 126 ± 19 94±25 9.3 33 NS NS 
(staged) 
5 IB 186 ± 127 184 ± 93 154 ± 51 1.0 17 <0.05 NS 72±49 229 ± 88 +218 <0.01 
6 pes + IB 185 ± 45 158 ± 31 161 ± 36 19 13 NS NS 63 ± 15 87 ± 40 +38 NS 
7 pes + IB 155 ± 35 121 ± 28 120 ± 39 22 33 NS NS 59 ± 16.1 53.5 ± 26' -10.1 NS 
(staged) 
• The per cent chaaps of Group 2 were compared with thOlle in Group 1 (control) and those in Groups 4 to 7 were compared to thOlle in Group 3 (control). 
• NS. not signifiC8D1t. 
, The results were beIore the Stage 2 operation and thus reflected PCS alone. 
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TABLE 5. EFFECT OF EXPERIMENTS ON SERUM BILE ACIDS 
Bile acids (I'M/liter) p. 
Group Description 
2 weeks Sacrifice Before 2 weeks Sacrifice 
1 PCS 2.67 ± 1.38 134 ± 104 75.59 ± 55.3 
2 PCS+BF 5.50 ± 4.2 43 ± 40.9 61.25 ± 60.0 <0.05 NS· 
3 PCS 5.26 ± 5.79 208 ± 71.6 190.8 ± 144.4 
4 PCS + BF (staged) 2.46 ± 1.01 93 ± 67.9" 16.18 ± 11.3 <0.05 <0.05 
5 IB 3.80 ± 2.79 4.9 ± 3.3 4.43 ± 2.1 <0.001 <0.001 
6 PCS + IB 2.66± 2.65 41.1 ± 25.3 91.14 ± 46.6 <0.001 NS 
7 PCS + IB (staged) 5.60 ± 6.3 170.1 ± 74.4< 29.26 ± 25.7 NS <0.05 
• Statistical comparisons (Student's t test) were of Group 2 VB. Group 1 (control) and Groups 4 to 7 vs. Group 3 (control). 
b NS, not significant. 
< The results at 2 weeks reflected PCS alone. 
TABLE 6. DOGS IN GROUP C WITH BILIRUBIN> OR';; 1.2 MG 
Mevalonic acid Cholesterol Bile acids Hepatocyte No. of labeled 
No. Bilirubin SGOT (nm/liter) (mgm%) E~/literF size units hepatocytes/l.000 of 
dogs (mgm%) (mU) Preopera- Preopera- Preopera- S . fi Hepatocyte 2 weeka Sacrifice f I acn Ice Before Sacrifice tively tively lvey Sacrifice 
",1.2 5 X 4.5 54.2 75.5 133 234.8 136 7.4 96.8 0.38 0.16 13.8 
± S.D. 1 27.6 48.0 71 135.4 15.6 5.8 56.7 0.09 0.03 0.8 
<1.2 5 X 1.1 26.8 84.3 87.8 156.8 115.2 3.9 45.6 0.34 0.16 14 
± S.D. 0.2 10.5 88.9 68.6 18.9 24.2 2 56.9 0.05 0.03 1.5 
P 0.001 NS' NS NS 
• NS. not significant. 
processes (5-9). It was long thought that the hepatic 
histopathologic and functional changes caused by Eck 
fistula were a unique feature in dogs. It is now established 
that these alterations are similar if not identical in all 
species so far studied including rats, dogs, swine, sub-
human primates, and humans (2, 5, 6) even though 
humans and rats are unusually resistant to the compli-
cations of hepatic encephalopathy (3, 5). 
NS 
The present study was undertaken in dogs in an at-
tempt to verify observations by Balabaud et a1. (10) and 
Bioulac et a1. (11) in rats that BF reverses the hepatic 
changes caused by pes, and to see if the same effect 
could be achieved with IB. pes (1, 6), BF (22), and IB 
(14) all cause reductions in serum cholesterol levels. The 
changes in cholesterol and bile acid metabolism resulting 
from each of the three procedures have been thoroughly 
studied. 
pes causes a reduction in cholesterol synthesis (6,13, 
23-30) and bile acid synthesis (13, 24,30,31). Interrup-
tion of the venous enterohepatic circulation has been 
one presumed cause of the elevation in postprandial 
serum bile acids caused by pes (12, 13). 
Many of the metabolic effects of either BF or IB alone 
are opposite to those of pes and reflect a response to 
increased bile salt and cholesterol losses. After BF, he-
patic cholesterol synthesis (22,32-35) and bile acid syn-
thesis (22, 35, 36-40) are increased many times. After 
IB, the same increases are seen in cholesterol (14, 41-
43) and bile acid (43, 44) synthesis. 
Bioulac et a1.'s hypothesis (11) was that BF in rats 
reversed or prevented the liver injury of pes by reducing 
the exposure of the liver to the high levels of serum bile 
acids which are caused by pes or, alternatively by stim-
NS NS NS NS NS NS 
ulating bile acid synthesis. Detailed discussion of such 
possible mechanisms would be superfluous since our 
canine experiments did not confirm a protective effect. 
In dogs, the failure of either BF or IB to alter the 
morphologic changes caused by pes was nearly absolute. 
Although the animals with BF or IB plus pes tended to 
have higher liver weight per body weight ratios at the 
time of sacrifice than dogs with pes alone, part of this 
effect may have been due to a greater average body weight 
loss during the 2 to 4 weeks after the multiple procedures. 
The possibility that the hepatic atrophy of pes had been 
reduced by BF or IB was not supported by quantitative 
histopathologic analyses of hepatocyte size. Further-
more, the addition of BF and IB did not alter the in-
creased rate of cell renewal and the organelle disruptions 
that are characteristic after pes (5-7). Although some 
of the dogs with BF in Group 2 had imperfect bile 
drainage and consequent jaundice, the results in these 
animals were no different than in others in Group 2 
which did not have rises in serum bilirubin, nor did the 
factor of jaundice alter the results of the lipid, mevalonic 
acid, and bile acid studies. 
It is possible that the data from the canine and rat 
studies were not as discordant as their divergent inter-
pretations. Major weight loss occurred in our dogs after 
pes and in the rats studied by Bioulac et al. (11). In 
both species, the liver weight per body weight ratios at 
the time of sacrifice were higher with the addition of BF, 
but the extent of hepatocyte atrophy was profound in 
both species when this was assessed by sophisticated 
histopathologic measurement of the size of hepatocytes. 
In the experiments of Bioulac et al. (11), the hepatocytes 
after pes shrank by 41 % compared to results after sham 
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pes; after pes plus BF at a second stage, the shrinkage 
was still 31 % compared to that in control rats after sham 
pes and BF. Thus, it would be incorrect to say that 
atrophy had been prevented by BF. The main difference 
between the rat and dog experiments was the seeming 
reversal by BF in the rat of many of the hepatocyte 
organelle changes caused by pes including disorganiza-
tion of the rough endoplasmic reticulum. In the dog, 
there was no evidence at all of this ameliorating effect 
with BF or with the bile salt depleting procedure of IB. 
In the present study, an attempt was made with bio-
chemical analyses of serum or plasma to assess the 
interaction of pes with the mechanistically opposing 
procedures of BF and lB. These were in no sense con-
trolled metabolic investigations since all of the animals 
were in a catabolic state with weight losses that ranged 
from 14 to 25% during the 3 to 4 weeks of study. Never-
theless, observations were possible which might have 
clinical relevance since pes and IB have been used 
together with an apparently cumulative effect to lower 
the serum cholesterol of at least three patients with 
familial hypercholesterolemia (45, 46). Guzman et a1. 
\ 4 7) have seen similar cumulative effects in dogs after 
portal diversion (by means of portacaval transposition) 
plus ileal resection. However, it is theoretically possible 
that procedures such as IB, BF, and ileal resection, which 
increase the enteric losses as well as the hepatic synthesis 
of cholesterol and bile acids, could subvert the antilipi-
demic mechanisms of pes which are thought to derive 
mainly from depressed hepatic cholesterol synthesis (3, 
6, 13, 23-30). 
The possibility of a cancelling effect of combined pro-
cedures was demonstrated from our animal studies. Dur-
ing the 3 or 4 weeks of observation, the anticholestero-
lemic effect of pes was approximately the same with or 
without BF or lB, and thus there was not an obvious 
advantage in combining the procedures. After IB alone, 
estimation of cholesterol synthesis by plasma mevalonic 
acid determination (20) indicated a 3-fold increase as 
expected. When IB (or BF) was combined with pes, the 
mevalonic acid rise was not eliminated. However, it was 
greatly reduced, reflecting the inability of the Eck fistula 
liver to fully respond to the stimulus of lB. These find-
ings do not preclude the probity of further clinical trials 
using pes and IB together in selected patients with 
familial hypercholesterolemia inspite of a further precau-
tionary note by Rucker et a1. (48). They reported 3-year 
follow-ups on the dogs described by Guzman et a1. (47) 
on which portal diversion and ileal resection were ini-
tially complementary. This additive effect eventually was 
lost. 
In the past, the extraordinary increases in postprandial 
plasma bile acids seen after pes have been ascribed in 
part to disconnection of the enterohepatic bile acid cycle 
(12, 13). Observations in our dogs emphasized that this 
is not the only factor since elimination of the hepatic 
source of enteric bile acids did not prevent but only 
reduced rises in plasma bile acids after a meal. The 30-
to 40-fold increases following pes were less if BF and 
IB were also performed, but even with pes and total 
external bile diversion (Groups 2 and 4) the postprandial 
rises were still 7 to 13 times above the baseline. In 
contrast, animals with IB as the sole procedure had no 
increase at all. Bioulac et a1. (11) have speculated that 
the Eck fistula liver can respond to BF with an attempt 
at heightened bile acid synthesis, but even if this were 
true, the response would be predicted to be subnormal 
(13,24,30,31); bile acid synthesis was not measured in 
our experiments. It seems most likely that the liver injury 
of Eck fistula renders the hepatic clearance of bile acids 
less efficient, since elevations of serum bile acids have 
been described in a wide range of liver diseases (49, 50). 
In their original canine studies, Horak et a1. (12) drew 
attention to the probable role of depressed hepatic clear-
ance of bile acids, and Poupon et a1. (51) came to the 
same conclusion from studies in patients before and after 
portacaval shunting. 
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